Nunyara Pharma secures licence to manufacture medical cannabis


The Australian Office of Drug Control (ODC) has granted Australian medicinal cannabis company Nunyara Pharma a licence to manufacture medicinal cannabis for extracts and tinctures of cannabis and cannabis resin. Founded in 2014 to participate in the emerging Australian medicinal cannabis market, Nunyara submitted licence applications for cultivation and manufacture to the Office of Drug…

This content is available exclusively to subscribers.
Log In Register